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ABSTRACT
Introduction: Whiplash-associated disorder (WAD)
causes substantial social and economic burden
internationally. Up to 60% of patients with WAD
progress to chronicity. Research therefore needs to
focus on effective management in the acute stage to
prevent the development of chronicity. Approximately
93% of patients are classified as WADII (neck
complaint and musculoskeletal sign(s)), and in the UK,
most are managed in the private sector. In our recent
systematic review, a combination of active and
behavioural physiotherapy was identified as potentially
effective in the acute stage. An Active Behavioural
Physiotherapy Intervention (ABPI) was developed
through combining empirical (modified Delphi study)
and theoretical (social cognitive theory focusing on
self-efficacy) evidence. This pilot and feasibility trial
has been designed to inform the design of an
adequately powered definitive randomised controlled
trial.
Methods and analysis: Two parallel phases. (1) An
external pilot and feasibility cluster randomised double-
blind (assessor and participants), parallel two-arm
(ABPI vs standard physiotherapy) clinical trial to
evaluate procedures and feasibility. Six UK private
physiotherapy clinics will be recruited and cluster
randomised by a computer-generated randomisation
sequence. Sixty participants (30 each arm) will be
assessed at recruitment (baseline) and at 3 months
postbaseline. The planned primary outcome measure is
the neck disability index. (2) An embedded exploratory
qualitative study using semistructured indepth
interviews (n=3–4 physiotherapists) and a focus group
(n=6–8 patients) and entailing the recruitment of
purposive samples will explore perceptions of the
ABPI. Quantitative data will be analysed descriptively.
Qualitative data will be coded and analysed deductively
(identify themes) and inductively (identify additional
themes).
Ethics and dissemination: This trial is approved by
the University of Birmingham Ethics Committee
(ERN_15-0542).
Trial registration number: ISRCTN84528320.
INTRODUCTION
Whiplash-associated disorder (WAD)
describes the variety of symptoms experi-
enced after a whiplash injury, caused by
rapid acceleration–deceleration of the head
and neck, most commonly following road
trafﬁc accidents.1 The estimated annual eco-
nomic cost related to motor vehicle crashes
is $242 billion in the USA2 and €180 billion
in Europe.3 WAD is associated with an
increase in healthcare costs, reduced work
productivity, lost earning capacity, socio-
economic costs and time contributed by
caregivers.4 5 For example, within the ﬁrst
2 years after a whiplash injury, employment
propensity declined by 20–25%.4
Approximately 60% of patients with WAD
progress to chronicity with up to 30% experi-
encing moderate to severe pain and disabil-
ity,6–8 leading to an decrease in quality of
life.9 10 Unfortunately, chronic WAD manage-
ment is reported to have limited
success.6 7 11 12 A focus on effective manage-
ment in the acute stage is therefore required
and may be able to prevent patients progres-
sing to chronicity.11 13 14
Strengths and limitations of this study
▪ This is the first pilot and feasibility trial of the
Active Behavioural Physiotherapy Intervention
(ABPI), which may be a potential useful interven-
tion in preventing patients with acute
whiplash-associated disorder (WAD) II progres-
sing to chronicity.
▪ Employing qualitative and quantitative methods,
this trial is designed to evaluate procedures,
feasibility and acceptability of the ABPI in man-
aging acute WADII within the UK insurance
private sector.
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Over the past decade, an increase in minor cervical
spine injuries and related costs after whiplash has been
reported from insurance companies.15 In the Western
World, the cost of insurance claims is considerable, par-
ticularly in the UK where a substantial proportion of
patients with WAD are managed within the private
sector (private physiotherapy clinics) through insurance
companies.15–21 The UK has also been described as the
‘whiplash capital of Europe’ by the Association of British
Insurers, who estimated that one person in 140 claims
for whiplash injury annually.19 In the UK, it is estimated
that the cost of claims for personal injury have risen
from £7 billion to £14 billion over the past decade.19
WAD has been classiﬁed into ﬁve grades.1 WADII
(neck complaint and musculoskeletal sign(s))
describes at least 70% of patients with whiplash,22 23 who
are commonly managed by physiotherapists. In the UK,
patients with WADII are usually referred to private
physiotherapy clinics.19 Therefore, evaluating the effect-
iveness of management of WAD in the private context is
important.
Our systematic review of randomised controlled trials
(RCTs)13 14 evaluating the effectiveness of acute WADII
management found that active intervention may be
useful for pain reduction medium (95% CI −17.19 to
−3.23, p=0.004) to long term (95% CI −26.39 to −10.08,
p<0.0001). Interestingly, the active intervention is also
strongly recommended within whiplash management
guidelines.24 25 Second, the review suggested that behav-
ioural intervention may be effective for pain reduction
medium term (95% CI −15.37 to −1.55, p=0.016) and
improvement of cervical mobility in the coronal (95%
CI 0.93 to 4.38, p=0.003) and horizontal planes (95% CI
0.43 to 5.46, p=0.027) short–medium term compared
with a standard/control intervention. The combination
of active physiotherapy and behavioural interventions,
termed ‘Active Behavioural Physiotherapy Intervention
(ABPI)’, may be a useful strategy for acute WADII man-
agement to prevent chronicity.14
The existing evidence was inadequate to generate an
intervention for managing patients with acute WADII.
Therefore, the ABPI was developed using empirical
(a modiﬁed Delphi study by international whiplash
researchers, UK private physiotherapists and UK post-
graduate musculoskeletal physiotherapy students)
(T Wiangkham, J Duda, MS Haque. The development
of an Active Behavioural Physiotherapy Intervention
(ABPI) for acute Whiplash Associated Disorder (WAD)II
management: a modiﬁed Delphi study. (Under review)
2016) and theoretical perspectives (social cognitive
theory focusing on self-efﬁcacy theory)26 in line with the
Medical Research Council Framework of Complex
Interventions.27 Having developed the intervention
through a rigorous process, it is now important to
explore the feasibility of delivering the intervention in
preparation for a future deﬁnitive cluster randomised
trial. For the UK, the delivery of the ABPI needs to take
place in the private setting.28
Aims and objectives
To evaluate procedures, feasibility and acceptability of
the ABPI in managing acute WADII within the UK insur-
ance private sector to inform the design and sample size
requirements for a future deﬁnitive randomised con-
trolled trial.
Primary objectives:
▸ To evaluate the feasibility of procedures for a cluster
randomised controlled trial (eg, randomisation,
recruitment, collecting data, trial management and
follow-up).29–32
▸ To evaluate the acceptability of the developed
intervention.30
▸ To evaluate recruitment rates, refusal rates, compli-
ance of participants in the private sector in the
UK.30 31
▸ To evaluate loss of follow-up of participants in the
private sector in the UK.30 32
Secondary objectives:
▸ To estimate the required sample size for a clustered
deﬁnitive trial.30–34
▸ To evaluate the feasibility of data collection for cost-
effectiveness analysis.30
METHODS
This trial will be conducted according to a predeﬁned
protocol (and subsequent deviations will be reported) to
minimise potential biases. It follows the Standard
Protocol Items: Recommendations for Interventional
Trials (SPIRIT) reporting guidelines to ensure sufﬁcient
transparency for protocols of clinical trials.35 Research
methods and reporting are in accordance with the
CONSORT 2010 statement: extension to cluster rando-
mised trials36 for phase I and COnsolidated criteria for
REporting Qualitative research (COREQ): a 32-item
checklist for interviews and focus groups37 for phase II.
Trial design
There are two phases to this trial.
Phase I
An external pilot and feasibility trial of a prospective,
cluster randomised double-blind (assessor and partici-
pants), parallel two-arm design, comparing ABPI with
standard physiotherapy management, will evaluate pro-
cedures and feasibility of the ABPI. Six private physio-
therapy clinics in the West Midlands, UK will be
recruited (ﬁgure 1). There are many advantages of
cluster randomisation in terms of administrative conveni-
ence,38 obtaining cooperation of investigators, ethical
considerations,38 enhancing participant compliance,
reducing treatment contamination,28 36 38 39 participant
blinding36 and logistical conveniences.38 However, the
required sample size in a cluster RCT is larger than an
RCT.40
Six private physiotherapy clinics will be invited to sign
consent forms (cluster-level consent) prior to cluster
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randomisation.36 Following randomisation, consecutive
potential participants, referred from an insurance
company, will be screened and recruited by a clinical
administrator by telephone to book an initial recruit-
ment appointment. The Participant Information Sheet
and consent form will be sent via email/post to inter-
ested patients to give them the opportunity to read it in
advance of the appointment. At the appointment, the
recruiting physiotherapist will discuss any issues relating
to the trial, conﬁrm eligibility and obtain written
consent (individual-level consent). Following informed
written consent, participants will be assessed on all
outcome measures by a blinded assessor using standar-
dised instruments with established measurement proper-
ties. Assessments will be taken at baseline (following
recruitment and consent) and at 3 months postbaseline.
All outcome assessments will be independent from treat-
ment sessions and treatment clinics to ensure that the
assessor is blinded to treatment allocation. The assessor
will be a physiotherapist familiar with the outcome
measures, and blinded to reduce potential biases. The
assessor will not be able to access the booking system
and participants’ information, whereas participants will
not know which intervention arm they will be allocated
to ensure that assessor and participants will be blinded.
At the end of the 3-month follow-up for each partici-
pant, the assessor will be asked ‘what intervention the
patient had received’ and the participants will be asked
which intervention arm they had allocated to evaluate
the blindness. Two assessment centres central to all
clinics will enable convenient attendance for partici-
pants. Participants will receive a reminder 2 days prior to
the baseline assessment and 3-month follow-up.
Providing a reason for participants’ withdrawal is volun-
tary. In the consent form, participants will be asked to
conﬁrm if they would like their data removed or kept in
the trial, in the situation that they would like to withdraw
from the trial (please see online supplementary appen-
dices for the participant information sheet and consent
form).
Figure 1 CONSORT flow diagram (adapted from CONSORT 2010). WAD, whiplash-associated disorder.
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Phase II
An embedded qualitative study will explore the accept-
ability of the ABPI for participants and physiotherapists,
and to explore how trial procedures and processes
worked in practice.41 The qualitative study will employ
two methods, namely semistructured individual inter-
views for physiotherapists and a focus group for partici-
pants from phase I. Potential participants in either
method will be invited via email including an attached
participant information sheet and consent form. Prior
to performing individual interviews and the focus group,
the participants will receive an opportunity to ask ques-
tions in order to decide whether they wish to complete
the consent form. Demographic characteristics of the
participants such as age, gender, occupation and ethni-
city will be collected and reported.37 Interviewer, moder-
ator and facilitator will be independent from trial
interventions, physiotherapy clinics and insurance com-
panies to ensure conﬁdential discussion and avoid
potential biases. Transcripts will be returned to partici-
pants for any comment and clariﬁcation.42 The lead
researcher (TW) will be trained in individual and focus
group interviews to enhance his qualitative skills prior to
conducting an interview.
Personal characteristics of research team
▸ TW (male): MRes AHR, BSc PT (Hons), Cert GCP,
MTPTC. Doctoral Researcher
▸ AR (female): EdD, MSc, Grad Dip Phys, Cert Ed, Dip
TP, FCSP, Health and Care Professions Councils
(HCPC), FHEA, FMACP. Senior Lecturer in
Physiotherapy and Academic Lead Physiotherapy
▸ JD (female): PhD, MSc, BA. Professor of Sport and
Exercise Psychology
▸ MSH (male): PhD, MSc, BSc (Hons), FRSS. Senior
Lecturer in Medical Statistics
▸ JP (male): BSc PT. Head of Professional Development
Individual interviews for physiotherapists in the experimental
arm
All physiotherapists who deliver the ABPI (3–4 phy-
siotherapists) will be invited to an individual face-to-face
interview by the lead researcher (TW) using a semistruc-
ture interview technique.41 43 Each interview, which will
take ∼60 min and take place at physiotherapists’ clinics,
will explore the opinions about attitudes towards and
acceptance of the ABPI in managing acute WADII.
Furthermore, perceptions of the similarities and differ-
ences between standard physiotherapy and the ABPI will
be examined. Topic guides for individual interviews will
be tested by TW at least two times prior to implementa-
tion (table 1). The interview will be noted, audio
recorded and transcribed by TW.
Focus group for participants in the experimental arm
A random sample of 6–8 participants who received the
ABPI will be invited via email to participate in a focus
group which is a standard and common procedure for
evaluating the acceptability of an intervention.42–44
There are several advantages of the focus group includ-
ing reduced economic compared with one-on-one inter-
views, and the points that focus groups are conducive to
tapping variability in attitudes and opinions due to the
interaction facilitated, and provide a comfortable forum
for the expression of individual and collective points of
view.45 A reminder email regarding date, time and loca-
tion of the interview will be sent to the participants
1 day prior to the focus group. The focus group inter-
view/discussion will last for ∼1.5 hours, be held at the
University and be led by an expert facilitator (AR) with
a moderator (TW) to observe group interaction/dynam-
ics and record main themes of discussion. An important
reason for using an expert facilitator is to obtain sufﬁ-
cient quality of the data and to avoid potential biases
(eg, consistency bias and dominant respondent bias).45
The focus group topic guide will include the interven-
tion that the participants received, the opinions and atti-
tudes of the participants about the intervention, how
the participants accepted the intervention and if and
how behaviour has changed. Following consent, the
focus group will start by agreeing ‘ground rules’ for the
group, including not discussing the content of the
group interview outside of the session. The facilitator
will start with an introduction for the study and organise
questions from general to speciﬁc related to interesting
topics (table 2). The focus group will be observed,
Table 1 Individual interview theme for the
physiotherapists in the experimental arm
Themes Questions
1 Opinions and attitudes for the new intervention
Did you have any obstruction in using the ABPI
for treating your patients?
Do you think the ABPI is useful for acute WADII
management? Why? Or why not?
What is your opinion regarding the most
effective treatment of WADII?
What should be the treatment for acute WADII?
With prompts for detail and elaboration of points
2 Similarities and differences between the
standard physiotherapy and the ABPI
What are the similarities and differences
between standard physiotherapy and the ABPI?
Which intervention do you feel may be more
helpful in managing your patients? Why?
With prompts for detail and elaboration of points
3 Acceptance of the new intervention
Is the ABPI an effective intervention for acute
WADII management? Why? Or why not?
Do you think the ABPI should be used in
managing acute WADII in general? Why?
Would you like to change/modify the ABPI? If
so how?
With prompts for detail and elaboration of points
ABPI, Active Behavioural Physiotherapy Intervention; WAD,
whiplash-associated disorder.
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noted, audio recorded and transcribed by TW. The par-
ticipants’ names will not be linked to any information in
the reporting of ﬁndings from the group discussion, and
ﬁndings will be reported for the whole group rather
than for individual participants. After the focus group,
the moderator and facilitator will discuss the main ﬁnd-
ings and unexpected outcomes.42
Participants
Participants will be recruited from six UK private physio-
therapy clinics. Demographic characteristics, including
age, gender, accident history, present drugs, information
regarding WAD symptoms, will be taken by the blinded
assessor at the baseline assessment. The participants in
this trial can normally claim all expenditures regarding
their treatment sessions from their insurance company.
The trial will pay for the participants’ journeys at base-
line and 3-month follow-up that are additional contact
points.
Eligibility criteria for clusters: private clinics in the West
Midlands, UK. Preliminary data have identiﬁed that
each clinic has at least two patients presenting with
acute WADII each month.
Inclusion criteria: Participants aged 18–70 years old, pre-
senting with WAD grade II (neck complaint and muscu-
loskeletal sign(s))1 from a road trafﬁc accident within
the previous 4 weeks.7 14 25 46–48
Exclusion criteria: Signs and symptoms of upper cervical
instability49 or cervical artery dysfunction,50 suspected
serious spinal pathology, open wounds, active inﬂamma-
tory arthritis, tumours, infection of the skin and soft
tissue, bleeding disorders or using anticoagulant medica-
tion,49 any current or previous treatment from any other
third party or presenting with any serious injuries from
other areas of the body resulting from the accident,
history of cervical surgery,51 previously symptomatic
degenerative diseases of the cervical spine within
6 months before the road trafﬁc accident,52 previous
history of whiplash or other neck pain,47 alcohol
abuse,52 53 dementia,52 53 serious mental diseases,52 53
psychiatric diseases54 55 and/or non-English speaking
and reading.
Interventions
Interventions are described based on Template for
Intervention Description and Replication (TIDieR).56
Participants in both intervention arms will attend
face-to-face physiotherapy sessions lasting for up to
30 min once a week in a private physiotherapy clinic.
The number of treatment sessions will vary between 6
and 8 sessions based on the individual physiotherapist’s
assessment. All physiotherapists in both intervention
arms will have a minimum of a Bachelor Degree in
Physiotherapy with 2 years of postregistration experi-
ence, and will be registered with the HCPC. To evaluate
ﬁdelity of the ABPI, a summary of treatment sessions will
be systematically collected and sessions will be randomly
observed by the lead researcher (TW). This will enable
monitoring and feedback regarding the intervention to
the treating physiotherapist.
Standard physiotherapy intervention
Patients will be managed according to current practice
reﬂecting the recommendations provided in the clinical
whiplash guidelines.24 25 48 Physiotherapy interventions
such as reassurance, education, manual therapy, exercise
therapy and physical agents, including a home pro-
gramme of exercises, are part of management depend-
ing on the individual physiotherapist’s clinical reasoning
for the individual patient. The treating physiotherapists
select appropriate interventions based on examination
ﬁndings and clinical reasoning.50
Active Behavioural Physiotherapy Intervention
The speciﬁc detail of this intervention including the under-
lying principles (eg, return to normal function/movement
as soon as possible, encourage self-management, and
Table 2 Focus group theme for the participants in the
experimental arm
Themes Questions
1 Intervention
What was treatment that you received from your
physiotherapist?
How did your physiotherapist approach you?
What was home programme that you were
recommended to do by your physiotherapist?
What did your physiotherapist suggest for
managing your symptoms?
With prompts for detail and elaboration of points
2 Opinions and attitudes for the new intervention
Do you think the treatment was useful? Why?
Or why not?
What is your opinion of this treatment for WAD?
What should be the treatment for acute WAD?
Would you suggest anything in your treatment
be changed or modified?
Was there anything missing?
With prompts for detail and elaboration of points
3 Acceptance of the new intervention
How did you feel after receiving the treatment?
Do you accept the treatment that your
physiotherapist gave to you? Why?
What is/are the benefit(s) of the treatment that
you received from your physiotherapist?
Do you think the treatment should be used for
acute WADII management? Why? Or why not?
With prompts for detail and elaboration of points
4 Behavioural changes
What differences, in your lifestyle, did you
notice after receiving the treatment?
After going through this treatment, have you
committed to adopting a more healthy lifestyle?
If yes, how? If not, why not?
With prompts for detail and elaboration of points
WAD, whiplash-associated disorder.
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reduce fear avoidance and anxiety) and the speciﬁc treat-
ment components in physical (eg, exercise programmes
for stability and mobility) and psychological (eg, cognitive–
behavioural therapy, whiplash education, advice to act as
usual, reassurance, self-management and postural control
and education) aspects were developed by international
research and local clinical whiplash experts through a
modiﬁed Delphi method (T Wiangkham, et al Under
review). By consideration of empirical and theoretical per-
spectives in line with the Medical Research Council
Framework of Complex Interventions,27 social cognitive
theory (with a particular focus on self-efﬁcacy enhance-
ment) will be used to underpin the ABPI to manage the
patient with acute WADII.26 57 Past research has found self-
efﬁcacy to correlate with quality of life and health status in
physical (eg, pain and physical functions) and psycho-
logical (eg, anxiety and depression) perspectives in a
rehabilitation context.58 59
The ABPI for acute WADII management consists of
four phases in terms of the promotion of understanding,
maturity, stamina and coping (ﬁgure 2). Table 3 pre-
sents a summary of the ABPI for acute WADII manage-
ment. The number of treatment session in each phase
will vary depending on individual patients’ conditions
based on physiotherapist’s justiﬁcation. The recommen-
dation is ∼1–3 visits in each phase.
Training of physiotherapists in the experimental arm
to deliver the ABPI will be delivered in advance of data
collection. The training will consist of a group tutorial
and workshop followed by individual training sessions to
construct the concept of how to design the intervention
and how to manage patients with WADII using the ABPI
programme based on the ﬁndings of the subjective and
objective examinations, and evidence informed clinical
reasoning.50 The physiotherapists will have 4 weeks to
practise their skills embedded in the ABPI in managing
patients with acute WADII prior to participants’ recruit-
ment. They will be randomly observed by the lead
researcher (TW) every week before starting participant
recruitment and every month during data collection.
Feedback will be provided throughout the trial.
Outcomes
Planned primary outcome measure
The neck disability index (NDI) is a patient-reported
outcome measure and a valid, reliable and responsive
tool in assessing pain and disability of neck in acute and
chronic conditions.60–63 The NDI is a self-administered
questionnaire that includes 10 sections focusing on func-
tional activities such as pain intensity, personal care,
lifting, reading, headache, concentration, work, driving,
sleeping and recreation.60 Each section is scored 0–5,
with 5 representing the greatest disability. The sum is
calculated and converted into a percentage to indicate
the participant’s perceived level of disability.60 The NDI
is a robust predictor of outcome for acute WAD64 and
recommended to monitor patients with whiplash by
several clinical guidelines, including NHS Library, New
South Wales Motor Accidents Authority, British
Columbia Physiotherapy Association, Royal Dutch
Society for Physical Therapy and the South Australian
Centre for Trauma and Injury.25 48 62 Consequently,
several previous whiplash intervention trials have used
the NDI as the primary outcome.47 65
Planned secondary outcome measures
Visual analogue scale for pain intensity
The most common symptom in patients with whiplash is
pain.18 Pain will be measured using a 0 mm (no pain) to
100 mm (worst possible pain) visual analogue scale
(VAS),66 which is a simple and preferred tool for asses-
sing pain intensity, with high validity and reliability in
evaluating acute pain.67–69 The identiﬁcation of initial
pain intensity using the VAS has been found to be an
important prognostic factor in predicting poor recovery
in patients with acute whiplash.64 70
Cervical range of motion
Decreasing cervical mobility is a common ﬁnding in
patients with WADII.71 Cervical range of motion
(CROM) is highly sensitive and can be speciﬁcally tested
for discrimination between asymptomatic and symptom-
atic whiplash72 and for handicap prediction of acute
whiplash injury.73 In this trial, the CROM will be mea-
sured by the cervical range of motion device.74 The cer-
vical range of motion device is a highly valid and
reliable device in measuring CROM and is attached to
the head.75–77 The participant sits on a comfortable
chair with hips and knees ﬂexed to 90°. CROM measure-
ments are recorded three times in each movement direc-
tion. The mean of the three measurements will be used
for data analysis.
Figure 2 Active Behavioural Physiotherapy Intervention for acute whiplash-associated disorder II management.
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Table 3 ABPI for acute WADII management
Phases Strategies Goals Interventions
1.
Understanding
▸ Information
▸ Intervention/simple
task
▸ Challenge
▸ Evaluation
▸ Guide/feedback
▸ Increase self-efficacy to reduce
psychological stress and
confidence in exercises by
education.
▸ Initiate gentle exercise for
maintain/improve neck stability
and mobility.
▸ Promote self-management
psychological and physical
management.
▸ Increase self-efficacy using
physiotherapist provided verbal
persuasion with the aim of reducing
psychological stress and confidence in
exercises by whiplash education.
▸ Initiate gentle exercises and home
programmes including challenge for
neck stability and mobility exercises
(eg, isometric neck exercises, chin in
and active CROM with pain free).
▸ Promote self-management to include
psychological (eg, stress management
and relaxation techniques) and physical
(eg, pain reduction and physical
functions) aspects.
▸ Other physiotherapy programmes based
on clinical reasoning.
2. Maturity ▸ Improve
understanding
▸ Provide a variety of
task
▸ Challenge
▸ Evaluation
▸ Guide/feedback
▸ Increase self-efficacy to reduce
psychological stress and
confidence in exercises.
▸ Exercises for neck and shoulder
stability and mobility.
▸ Promote self-management for
pain and physical functions.
▸ Increase self-efficacy (reduce
psychological stress and improve
confidence in performing exercises)
– Performance accomplishment
(eg, relieve pain and increase
CROM);
– Verbal persuasion (eg, further
whiplash education/feedback when
patients need, continue exercises
with challenge);
– Increase emotional stages with good
relationship.
▸ Exercises+home programmes including
challenge for neck and shoulder stability
and mobility exercise (eg, resisted neck
and shoulder, and AROM exercises).
▸ Promote self-management for pain and
physical functions (psychological
management when patients need).
▸ Other physiotherapy programmes based
on clinical reasoning.
3. Stamina ▸ Maintain motivation
▸ Progress/complexity
of task
▸ Challenge
▸ Evaluation
▸ Guide/feedback
▸ Increase/maintain self-efficacy to
make confidence in
self-management and exercises.
▸ Progressive exercises for
stability and mobility.
▸ Promote self-management for
physical functions.
▸ Increase/maintain self-efficacy for
self-management and exercises
– Performance accomplishment
(eg, relieve pain, increase CROM,
improve physical functions);
– Verbal persuasion (eg, guide/
feedback, continue exercises with
challenge);
– Increase/maintain emotional stages
with good relationship.
▸ Progressive exercises+home
programmes including challenge for
strengthening and ROM exercises.
▸ Promote self-management for physical
functions.
▸ Other physiotherapy programmes based
on clinical reasoning.
Continued
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Pressure pain threshold
Pressure pain threshold (PPT) is measured using
minimal pressure force to identify the threshold of
stimulating pain.78 Patients with whiplash frequently
report regarding central hyperexcitability in acute
(<1 month)79–81 and chronic stages.82 The investigation
of PPT at remote pain-free muscles suggests that a com-
ponent of hypersensitivity in patients with whiplash may
come from central sensitisation.83 A digital pressure alg-
ometer is a highly valid and reliable instrument, used to
detect sensitivity of symptomatic areas and distal pain-
free areas.84 85 The speed of applied force is 30 kPa/s.81
The participants are required to press a button when
their sensation changes from pressure to perceived
pain.81 PPT will be assessed at the insertion of the
levator scapulae81 and the upper one-third of the tibialis
anterior muscle85 on both sides, three times each side,
with an interval of 1 min between each test.86 87 The
mean of the three measurements will be used for data
analysis. The starting position of the assessment is com-
fortable upright sitting with hip and knee ﬂex 90° for
the levator scapulae and supine lying with the knee of
an assessed side ﬂex 90° for the tibialis anterior.
Impact of events scale
The impact of event scale (IES) is a valid and reliable
15-item questionnaire assessing current stress and indicat-
ing the symptoms of post-traumatic stress88–90 that may
contribute to a high risk of persistent symptoms.54 91–93
The IES is recommended by some clinical whiplash
guidelines to monitor whiplash management.25 48
Fear-Avoidance Beliefs Questionnaire
The physical disability of patients with WAD can be inﬂu-
enced by fear-avoidance beliefs and associated beha-
viours following whiplash injury.94–96 Patients with
dysfunctional illness beliefs need to have these
addressed to prevent chronicity.97 The Fear-Avoidance
Beliefs Questionnaire is a 16-item valid and reliable tool
administered to patients with neck pain,98 to assess their
perceptions of the impact of physical activity and work
on their levels of pain and disability.
Assessment of outcome
Masked assessment of outcomes will take place at base-
line and at 3 months postbaseline. After 3 months, the
patients with whiplash who continue with symptoms and
problems are deﬁned as chronic.7 25 In the future deﬁni-
tive trial, the primary end point will be 3 months and
the number of recovered patients with WADII within
3 months will be evaluated. Longer term follow-up is
also planned to 1 year. Participants who do not attend
the 3-month follow-up assessment will be contacted by
telephone and asked if they would like to make a new
appointment. If they cannot make a new appointment,
the researcher will ask them to complete the NDI via
telephone interview, which has established reliability and
validity.99
Feasibility of cost-effectiveness analysis
Direct and indirect medical costs will be collected to
assess the feasibility of data collection for the planned
cost-effectiveness analysis in the deﬁnitive trial.
Participants will receive a diary pocket book to record
any activities related to whiplash management such as
using medication, consulting other health professionals;
along with any costs they incur, days of sick leave, bene-
ﬁts claimed that relate to whiplash management. In the
ﬁrst page of the diary pocket book, general information
on participants (eg, postcode, work status and income)
will be collected. Costs related to physiotherapy manage-
ment will be collected from the physiotherapy clinics.
Table 3 Continued
Phases Strategies Goals Interventions
4. Coping ▸ Strength
self-efficacy for
self-management
▸ Encourage healthy
lifestyle
▸ Evaluation
▸ Guide/feedback
▸ Maintain/increase self-efficacy
for self-management and
exercises.
▸ Promote self-management for
physical functions.
▸ Facilitate long-term goal for
healthy lifestyle.
▸ Maintain/increase self-efficacy
– Performance accomplishment
(eg, physical functions);
– Verbal persuasion (eg, guide/
feedback, continue exercises with
challenge to be a healthy lifestyle
person);
– Increase/maintain emotional stages
with good relationship.
▸ Home programmes for strengthening
and ROM exercises.
▸ Promote self-management for physical
functions.
▸ Facilitate the adoption/maintenance of a
healthy lifestyle.
▸ Other physiotherapy programmes based
on clinical reasoning.
ABPI, Active Behavioural Physiotherapy Intervention; CROM, cervical range of motion; WAD, whiplash-associated disorder.
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Training costs of physiotherapists in the experimental
ABPI arm will also be recorded. The quality-adjusted life
years will be estimated using the advocated EuroQol-5
Dimensions.100
Sample size
As this is a pilot and feasibility trial, a power calculation
is not required.30 Although establishing targeted sample
sizes for pilot/feasibility trials is controversial, 60 partici-
pants (30 per arm) will be recruited to provide sufﬁcient
power of parameters for designing an adequate power
randomised controlled trial.101 Data from the physio-
therapy clinics provided evidence of 18 eligible partici-
pants available per month across the six private
physiotherapy clinics. The recruitment rate of this trial
will be considered adequate if it is at least 50% of eli-
gible participants are recruited. Based on this estimate,
the trial may take 6–7 months for participant recruit-
ment with 3-month follow-up.
Randomisation
To minimise selection bias at the cluster level, a
computer-generated randomisation programme will be
used by the lead researcher (TW) to randomise six
private physiotherapy clinics into two groups: standard
physiotherapy intervention (n=3 clinics) and ABPI (n=3
clinics). Allocation will be concealed prior to assign-
ment. Only TW will be involved in this process. Cluster
randomisation will be implemented before participants
are recruited (see ﬁgure 1 for CONSORT ﬂow
diagram).
Data analysis
Phase I
Data will be analysed and summarised based on quan-
titative synthesis using a prespeciﬁed protocol to evalu-
ate eligible, recruitment and follow-up rates.
Quantitative data will be analysed using IBM SPSS
V.22. Descriptive statistics will assess the feasibility of
the ABPI for acute WADII management to inform the
design of the future deﬁnitive trial (table 4). The par-
ticipants who receive other treatments from the initial
randomised treatment allocation will not be disre-
garded in the trial and their data will be included in
intention-to-treat analyses. The planned primary end
point of this trial is evaluation of the NDI at 3-month
follow-up. Evaluation of the drop-out rate of partici-
pants will be a criterion to conﬁrm the primary end
point. Upon completion of the pilot and feasibility
trial, the following possible decisions will be consid-
ered by evaluating the feasibility criteria (table 4) for
conducting the deﬁnitive trial:31
Table 4 Feasibility assessment criteria
Objectives Criteria of success
To evaluate the feasibility of procedures (eg, randomisation,
recruitment, collecting data, management, follow-up)29–32
The trial will be considered feasible if this trial can be run
smoothly without serious problems or obstructions which are
able to stop the study.29 31
To investigate the acceptability of the developed
intervention30
The trial will be considered feasible if the physiotherapists and
the participants find the developed intervention acceptable.
To evaluate recruitment rates, refusal rates, retention,
compliance of participants in the private sector in the
UK30 31
The trial will be considered feasible if
▸ ≥50% of eligible participants can be recruited;
▸ at least three participants a week per intervention arm can
be recruited;
▸ ≥80% of all recruited participants complete the follow-up at
3 months.
To evaluate dropout rates of participants in the private
sector in the UK30 32
The trial will be considered feasible if ≤20% of all recruited
participants dropout.
To estimate the required sample for a definitive trial30–34 The trial will be considered feasible if the sample size for a
cluster RCT is feasible to achieve based on recruitment data.
To evaluate the feasibility of data collection for
cost-effectiveness analysis30
The trial will be considered feasible if the following components
of the cost-effective analysis can be collected with minimal
missing data.
▸ General information (eg, current work status and salary).
▸ Direct medical costs
– Medical costs (eg, physiotherapy, general practice and
complementary medicine);
– Resource uses (eg, diagnosis tests).
▸ Indirect medical costs
– Participant journey costs;
– Training costs for physiotherapists in the experimental
arm.
ABPI, Active Behavioural Physiotherapy Intervention; RCT, randomised controlled trial; WAD, whiplash-associated disorder.
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▸ Stop if the main trial is not possible or valuable.
▸ Continue but modify the protocol if the main trial is
possible and valuable.
▸ Continue without modiﬁcations but monitor closely if
the main trial is possible and valuable with close
monitoring.
▸ Continue without modiﬁcations if the main trial is
possible and valuable.
The intracluster correlation coefﬁcient will also be cal-
culated to prepare information for sample size calcula-
tion within a clustered deﬁnitive trial.
Phase II
Qualitative data of individual interviews and focus group
will be coded and by the lead researcher (TW). QRS
NVivo 10 will be employed to identify themes regarding
the acceptability of the ABPI to physiotherapists and par-
ticipants, and how trial procedures and processes
worked in practice.102 103 In the focus group, a key aim
of the analysis is to identify any emerging group consen-
sus regarding attitudes towards and experiences of the
ABPI.104 The participants’ name will not be linked to
any information in the reporting of ﬁndings from the
group discussion, and ﬁndings will be reported for
the whole group rather than for individual participants.
The data will be analysed deductively (to identify
themes) and inductively (to identify additional
themes).44 105 The analysis and ﬁndings emanating from
the qualitative data will be discussed with the research
team at each stage (TW, AR, JD and MSH). The
mapping and interpretation of the data will be used to
explore and explain relevant patterns. The interpret-
ation of qualitative data will be carried out in parallel to
the quantitative ﬁndings.
Trial management and monitoring
The trial will be managed by the Trial Management
Group consisting of TW, AR, JD and MSH. The trial
combines the Trial Steering Committee and the Data
Monitoring Committee functions in line with the nature
of the trial, into the Acute Whiplash Injury Study
(AWIS) Steering Group, consisting of TW, AR, MSH, JP,
a WADII patient, an external member and an independ-
ent chair. The committee will meet at the start of recruit-
ment, after 3 months of recruitment and at completion
of data collection. The lead researcher (TW) has quali-
ﬁed for Good Clinical Practice (certiﬁcate number:
33951-36-41796).
Adverse events
Adverse events in this trial are considered as low risk.
First, WADII (neck complaint and musculoskeletal sign
(s)) is not normally a cause of serious adverse
events.11 65 Second, the ABPI and standard physiother-
apy intervention are conservative treatments without
existing reporting of serious adverse events.11 65 As a
result, patients are unlikely to receive any serious harm
from either intervention. Generally, only minor adverse
events are likely to occur after the physiotherapy inter-
vention. The most common adverse events for the
physiotherapy intervention are muscle soreness that
commonly recovers within 1–2 days.106
Serious adverse events
This trial will have a very low risk of serious adverse
events in terms of patient pathology, treatment nature
and treatment management. Participants will be evalu-
ated by a physiotherapist prior to seeking consent to
ensure that the participants are classiﬁed as WADII (pre-
sented only musculoskeletal sign(s) without any neuro-
logical sign(s)) to meet the eligibility criteria, thereby
excluding patients with high severity. All physiotherapists
in this trial manage their patients based on the
International Federation of Orthopaedic Manipulative
Physical Therapists cervical framework50 that provides a
framework for clinical reasoning to avoid risk of any
adverse events regarding the vascularity and instability of
the neck from physical therapy intervention. However,
progressive symptoms within 3 days and admitted in the
hospital due to whiplash problems will be reported for
serious adverse events. If any serious adverse events
occur, the patients will be able to continue with the trial
when their symptoms are resolved.
Procedures for reporting adverse and serious adverse
events
An adverse event reporting form will be provided to all
clinics. If a participant experiences any unpleasant symp-
toms, they will be asked to report them to their physio-
therapist. The physiotherapist will report any event to
the researcher (TW) within 24 hours. The researcher
will report to the AWIS steering committee within
24 hours to enable analysis of the event and any
required action. Although this trial may have low risk of
adverse events, any sign(s) and/or symptom(s), which
would cause life-threatening situations, inpatient hospi-
talisation and signiﬁcant disability (eg, unable to work),
may occur. Any unexpected serious adverse events will
be immediately reported with a written form and verbal
contact by physiotherapists to the researcher (TW).
Then, the researcher will report to the AWIS steering
committee immediately.
Research governance
The trial will maintain research governance by using the
principles of the Research Governance Framework for
Health and Social Care.
Data management
All information collected on and from the participants
will be kept safely from any third party to maintain the
participants’ privacy. All collected documents will be
stored in a secure place. All electronic data will also be
conﬁdentially stored in a password protected computer
during the trial. Data can only be accessed by members
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of the research team. The ﬁndings will be submitted for
publication to medical journals and presented at confer-
ences and local seminars. The trial will only be pub-
lished in a completely unattributable format or at an
aggregate level in order to ensure that no participant
can be identiﬁed. After completing the trial, all data will
be destroyed after being kept for 10 years at the School
of Sport, Exercise and Rehabilitation Sciences,
University of Birmingham.
R&D considerations
NHS ethical approval and R&D approval is not required
as the trial sites are outside of the UK National Health
Service. The insurance/private clinics do not require any
other regulatory approval. Support for the trial is in place
by the private clinics and the insurance companies.
DISCUSSION
Before designing and conducting an adequate powered,
high-quality cluster RCT examining the ABPI for man-
aging acute WADII, this pilot and feasibility trial is
required. If the pilot and feasibility trial is successful
(ie, the ABPI is found to be feasible), a future deﬁnitive
trial will be implemented to compare the effectiveness of
the ABPI and standard physiotherapy intervention, inclu-
sive of cost-effectiveness analysis. If it is demonstrated that
the ABPI is effective in managing patients with acute
WADII, the ABPI will be a valuable intervention to prevent
patients with acute WADII progressing to chronicity.
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